Literature DB >> 16904320

Cell surface-associated mucins in signal transduction.

Pankaj K Singh1, Michael A Hollingsworth.   

Abstract

Mucins are heavily glycosylated high molecular weight glycoproteins, which are involved in the protection and lubrication of luminal epithelial surfaces. Transmembrane mucins also engage in signal transduction, through extracellular domain-mediated ligand binding or by interacting with receptors for growth and differentiation factors. The cytoplasmic tail of MUC1 (MUC1CT), the best characterized of the transmembrane mucins, is involved in several signaling pathways, including those involving Ras, beta-catenin, p120 catenin, p53 and estrogen receptor alpha. MUC1CT also forms complexes with transcription factors, and then translocates to the nucleus by an unknown mechanism, where it is believed to influence the transcription of their target genes. MUC1CT has also been proposed to localize to mitochondrial membranes under conditions of genotoxic stress, where it attenuates the apoptotic pathway in response and confers resistance to apoptosis-inducing drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904320     DOI: 10.1016/j.tcb.2006.07.006

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  173 in total

1.  Characterization of the Src/Abl hybrid kinase SmTK6 of Schistosoma mansoni.

Authors:  Svenja Beckmann; Steffen Hahnel; Katia Cailliau; Mathieu Vanderstraete; Edith Browaeys; Colette Dissous; Christoph G Grevelding
Journal:  J Biol Chem       Date:  2011-10-19       Impact factor: 5.157

Review 2.  Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells.

Authors:  S Bafna; S Kaur; S K Batra
Journal:  Oncogene       Date:  2010-03-29       Impact factor: 9.867

Review 3.  Regulation of airway mucin gene expression.

Authors:  Philip Thai; Artem Loukoianov; Shinichiro Wachi; Reen Wu
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

Review 4.  The ocular surface: the challenge to enable and protect vision: the Friedenwald lecture.

Authors:  Ilene K Gipson
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-10       Impact factor: 4.799

5.  Phosphorylation of MUC1 by Met modulates interaction with p53 and MMP1 expression.

Authors:  Pankaj K Singh; Michelle E Behrens; John P Eggers; Ronald L Cerny; Jennifer M Bailey; Kandavel Shanmugam; Sandra J Gendler; Eric P Bennett; Michael A Hollingsworth
Journal:  J Biol Chem       Date:  2008-07-14       Impact factor: 5.157

6.  Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma.

Authors:  Małgorzata Borzym-Kluczyk; Iwona Radziejewska; Marzanna Cechowska-Pasko
Journal:  Clin Exp Nephrol       Date:  2014-08-05       Impact factor: 2.801

7.  The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms.

Authors:  Heather C Workman; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

8.  Pathobiology of biliary epithelia and cholangiocarcinoma: proceedings of the Henry M. and Lillian Stratton Basic Research Single-Topic Conference.

Authors:  Alphonse E Sirica; Michael H Nathanson; Gregory J Gores; Nicholas F Larusso
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425

9.  MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Subhankar Chakraborty; Subhash C Chauhan; Sangeeta Bafna; Jane L Meza; Pankaj K Singh; Michael A Hollingsworth; Parmender P Mehta; Surinder K Batra
Journal:  Cancer Res       Date:  2008-04-01       Impact factor: 12.701

10.  MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.

Authors:  Takashi Kimura; John R McKolanis; Lynda A Dzubinski; Kazi Islam; Douglas M Potter; Andres M Salazar; Robert E Schoen; Olivera J Finn
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.